Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk factors of preterm delivery in HIV-infected pregnant women receiving zidovudine for the prevention of perinatal HIV.
Traisathit P, Mary JY, Le Coeur S, Thantanarat S, Jungpichanvanich S, Pornkitprasarn W, Gomutbutra V, Matanasarawut W, Wannapira W, Lallemant M. Traisathit P, et al. Among authors: pornkitprasarn w. J Obstet Gynaecol Res. 2009 Apr;35(2):225-33. doi: 10.1111/j.1447-0756.2008.00925.x. J Obstet Gynaecol Res. 2009. PMID: 19708170 Clinical Trial.
The interrelated transmission of HIV-1 and cytomegalovirus during gestation and delivery in the offspring of HIV-infected mothers.
Khamduang W, Jourdain G, Sirirungsi W, Layangool P, Kanjanavanit S, Krittigamas P, Pagdi K, Somsamai R, Sirinontakan S, Hinjiranandana T, Ardonk W, Hongsiriwon S, Nanta S, Borkird T, Lallemant M, McIntosh K, Ngo-Giang-Huong N; Program for HIV Prevention and Treatment (PHPT) Study Group. Khamduang W, et al. J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):188-92. doi: 10.1097/QAI.0b013e31822d0433. J Acquir Immune Defic Syndr. 2011. PMID: 21792064 Free PMC article.
Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine.
Lallemant M, Ngo-Giang-Huong N, Jourdain G, Traisaithit P, Cressey TR, Collins IJ, Jarupanich T, Sukhumanant T, Achalapong J, Sabsanong P, Chotivanich N, Winiyakul N, Ariyadej S, Kanjanasing A, Ratanakosol J, Hemvuttiphan J, Kengsakul K, Wannapira W, Sittipiyasakul V, Pornkitprasarn W, Liampongsabuddhi P, McIntosh K, Van Dyke RB, Frenkel LM, Koetsawang S, Le Coeur S, Kanchana S; PHPT-4 Study Team. Lallemant M, et al. Among authors: pornkitprasarn w. Clin Infect Dis. 2010 Mar 15;50(6):898-908. doi: 10.1086/650745. Clin Infect Dis. 2010. PMID: 20158398 Free PMC article.
Association between detection of HIV-1 DNA resistance mutations by a sensitive assay at initiation of antiretroviral therapy and virologic failure.
Jourdain G, Wagner TA, Ngo-Giang-Huong N, Sirirungsi W, Klinbuayaem V, Fregonese F, Nantasen I, Techapornroong M, Halue G, Nilmanat A, Wittayapraparat P, Chalermpolprapa V, Pathipvanich P, Yuthavisuthi P, Frenkel LM, Lallemant M; Program for HIV Prevention and Treatment (PHPT) Study Group. Jourdain G, et al. Clin Infect Dis. 2010 May 15;50(10):1397-404. doi: 10.1086/652148. Clin Infect Dis. 2010. PMID: 20377404 Free PMC article.